High Tech Price To Sales vs. Debt To Equity

106190 Stock  KRW 14,030  60.00  0.43%   
Considering the key profitability indicators obtained from High Tech's historical financial statements, High Tech Pharm may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess High Tech's ability to earn profits and add value for shareholders.
For High Tech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of High Tech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well High Tech Pharm utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between High Tech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of High Tech Pharm over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between High Tech's value and its price as these two are different measures arrived at by different means. Investors typically determine if High Tech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, High Tech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

High Tech Pharm Debt To Equity vs. Price To Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining High Tech's current stock value. Our valuation model uses many indicators to compare High Tech value to that of its competitors to determine the firm's financial worth.
High Tech Pharm is number one stock in price to sales category among its peers. It also is number one stock in debt to equity category among its peers fabricating about  0.01  of Debt To Equity per Price To Sales. The ratio of Price To Sales to Debt To Equity for High Tech Pharm is roughly  83.14 . Comparative valuation analysis is a catch-all model that can be used if you cannot value High Tech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for High Tech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

High Debt To Equity vs. Price To Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

High Tech

P/S

 = 

MV Per Share

Revenue Per Share

 = 
0.83 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

High Tech

D/E

 = 

Total Debt

Total Equity

 = 
0.01 %
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

High Debt To Equity Comparison

High Tech is currently under evaluation in debt to equity category among its peers.

High Tech Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in High Tech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, High Tech will eventually generate negative long term returns. The profitability progress is the general direction of High Tech's change in net profit over the period of time. It can combine multiple indicators of High Tech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
High Tech Pharm Co., Ltd. develops, manufactures, sells, and distributes antibiotic pharmaceutical ingredients for injections for hospitals and doctors.

High Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on High Tech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of High Tech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the High Tech's important profitability drivers and their relationship over time.

Use High Tech in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if High Tech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in High Tech will appreciate offsetting losses from the drop in the long position's value.

High Tech Pair Trading

High Tech Pharm Pair Trading Analysis

The ability to find closely correlated positions to High Tech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace High Tech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back High Tech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling High Tech Pharm to buy it.
The correlation of High Tech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as High Tech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if High Tech Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for High Tech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your High Tech position

In addition to having High Tech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aluminum Thematic Idea Now

Aluminum
Aluminum Theme
Companies involved in production of aluminum. The Aluminum theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aluminum Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in High Stock

To fully project High Tech's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of High Tech Pharm at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include High Tech's income statement, its balance sheet, and the statement of cash flows.
Potential High Tech investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although High Tech investors may work on each financial statement separately, they are all related. The changes in High Tech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on High Tech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.